Table 2. Events Occurring Within 6 Months of First Prescription of Guideline-Recommended Hypnotics.
| Outcome | Treatment group, No. (%) of patientsa | |||||
|---|---|---|---|---|---|---|
| Eszopiclone (n = 34 050) | Ramelteon (n = 14 523) | Suvorexant (n = 37 547) | Zolpidem (n = 135 492) | Triazolam (n = 17 956) | All (N = 239 568) | |
| Monotherapy failure | 4062 (11.9) | 2193 (15.1) | 4767 (12.7) | 12 066 (8.9) | 1690 (9.4) | 24 778 (10.3) |
| Monotherapy discontinuation | 24 857 (73.0) | 10 468 (72.1) | 27 538 (73.3) | 105 138 (77.6) | 13 622 (75.9) | 181 623 (75.8) |
| Continuation for 6 mo | 3627 (10.7) | 1268 (8.7) | 3564 (9.5) | 12 915 (9.5) | 1897 (10.6) | 23 271 (9.7) |
| Censored | 1504 (4.4) | 594 (4.1) | 1678 (4.5) | 5373 (4.0) | 747 (4.2) | 9896 (4.1) |
a
Percentages have been rounded and may not total 100.